The potential effects of clinical antidiabetic agents on SARS‐CoV‐2

BACKGROUND: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is currently posing significant threats to public health worldwide. It is notable that a substantial proportion of patients with sever COVID‐19 have coexisting diabetic conditions...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes
Autors principals: Qu, Hua, Zheng, Yi, Wang, Yuren, Li, Hongwei, Liu, Xiufei, Xiong, Xin, Zhang, Linlin, Gu, Jing, Yang, Gangyi, Zhu, Zhiming, Zheng, Hongting, Ouyang, Qin
Format: Artigo
Idioma:Inglês
Publicat: Wiley Publishing Asia Pty Ltd 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753367/
https://ncbi.nlm.nih.gov/pubmed/33210826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.13135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars